Omar Oakes
May 8, 2018

GSK reviews global media

Pharma giant GlaxoSmithKline has reportedly launched a review of its US $1.8 billion global media agency arrangements, putting MediaCom and PHD on alert.

GSK reviews global media

The review, which is being handled by ID Comms, comes less than three years after GSK awarded its European business to MediaCom, while PHD was handed its US media account.

Both agencies had retained the accounts in 2015 following a global media review, after having been first appointed in 2013.

A year later, GSK completed an agency review for the other parts of its marketing comms business by hiring nine agencies, including Grey and Saatchi & Saatchi for advertising.

GSK's agencies were appointed to work on the company's seven power brands (Sensodyne, Parodontax, Poligrip, Voltaren, Panadol, Theraflu and Otrivin) and 12 core brands (Biotene, Contac, Flonase, Excedrin, Fenbid, Tums, ENO, Horlicks, Physiogel, Lamisil, Fenistil and Abreva/Zovirax).

GSK did not respond to a request for comment by Campaign UK by press time while MediaCom and PHD would not comment and referred Campaign to GSK.

Source:
Campaign UK

Related Articles

Just Published

6 hours ago

Fred & Farid and the palette of AI possibilities

INSPIRATION STATION: Taking AI-generated art beyond the amateur hour, Fred & Farid redefines creative artistry for milestone anniversary celebrations.

7 hours ago

Asia-Pacific Power List 2023: Jan-Paul Jeffrey, Spotify

From localising campaigns to surprising fans with egg-cellent moments, Jeffrey’s marketing symphony in Southeast Asia is hitting all the right notes.

7 hours ago

A marketoonist’s hard truths about the industry

From shiny new distractions to fallacious funnels, cartoonist Tom Fishburne points out the obvious ridiculousness in our industry that most are blind to.

12 hours ago

'Legitimate anxiety': Anti-LGBTQ activists flex ...

Bud Light. Target. Kohl’s. Even Chick-fil-A. Brands know they could be the next to be targeted for celebrating Pride.